Jianling Ji

Jianling Ji, MD is a Clinical Associate Professor of Clinical Pathology at the University of Southern California. Her work focuses on molecular diagnostics, genomic analysis, and pediatric oncology. She is actively involved in translational research bridging genetic findings with clinical applications. Her research emphasizes improving diagnostic accuracy through advanced genomic techniques like optical genome mapping and RNA sequencing.

Her publications span topics including pediatric tumor characterization, genomic variant interpretation, and clinical trial outcomes for surgical oncology interventions. She collaborates on multi-institutional studies and contributes to guideline development for molecular pathology practices. Dr. Ji's work frequently addresses challenges in pediatric malignancies, including diagnostic yield optimization and resistance mechanisms in targeted therapies.

Key areas of contribution include: (1) Development of clinical sequencing assays for fusion gene detection in tumors, (2) Validation of liquid biopsy approaches for disease monitoring, (3) Standardization of genomic testing protocols through professional society collaboration, and (4) Analysis of rare genetic syndromes with complex phenotypic presentations. Her research demonstrates a strong focus on actionable genomic insights for clinical decision-making.